March 19, 2024, 12:23 a.m. | NVIDIA

NVIDIA www.youtube.com

Virtual screening for new medicines is a computationally intractable problem. Existing techniques can only scan billions of compounds and require days on thousands of standard compute nodes. NVIDIA BioNeMo microservices enable a new generative screening paradigm. Using a generated 3D protein structure as a guide, NVIDIA MolMIM generates, optimizes, and screens high-quality candidate molecules in a matter of minutes. Learn more here: build.nvidia.com/explore/healthcare

Key Points:

- BioNeMo allows us to build a virtual screening pipeline with microservices: protein folding, molecule …

bionemo compute generated generative guide medicines microservices molecules nodes nvidia nvidia bionemo paradigm protein protein structure quality screening standard virtual

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US